The primary objective of the Institute of Pharmacology and Structural Biology is the identification, characterization and exploitation of novel therapeutic targets in the fields of Cancer, Infection and Inflammation.
The IPBS is a joint research center of the CNRS and the University of Toulouse. Occupying 12,000 m2 in the heart of the main campus of the University of Toulouse III-Paul Sabatier, which offers high-level multidisciplinary training in the fields of science, health and engineering, the IPBS is part of one of the most important scientific research poles in health and biological sciences in France.
The IPBS currently hosts more than 230 scientific and administrative staff, including more than 40 PhD students and post-doctoral fellows of multiple nationalities, who work in a stimulating and highly collaborative environment. The IPBS currently comprises 15 research groups working in the fields of tissue and cell microenvironment biology, and of molecular and structural mechanisms of disease, as well as 4 state-of-the-art technological facilities in proteomics, biophysics and structural biology, molecular and cellular imaging, and functional exploration, including in several BSL-3 laboratories for the study of infectious diseases such as tuberculosis and other pulmonary and enteric infections, and more recently COVID-19.
Our teams are involved in numerous national and international networks, and our work is supported by prestigious funding (from the European Commission, including the ERC and the Marie Sklodowska-Curie program, the Bettencourt Schueller Foundation, the Bill and Melinda Gates Foundation, the NIH, MSDAVENIR, the Agence Nationale de la Recherche, the French National Agency for research on AIDS, the ARC Fondation for cancer research, the Ligue contre le cancer, and the Fondation pour la Recherche Médicale, to name a few).
With more than 100 scientific publications per year, many of them in prestigious journals, a dozen start-ups created since 2000, and multiple partnerships with industry and the clinic, IPBS is a world leader in the discovery, characterization, validation and exploitation of new biological targets in the fields of cancer, infection and inflammation.
Our teams are involved in numerous national and international networks, and our work is supported by prestigious funding (from the European Commission, including the ERC and the Marie Sklodowska-Curie program, the Bettencourt Schueller Foundation, the Bill and Melinda Gates Foundation, the NIH, MSDAVENIR, the Agence Nationale de la Recherche, the French National Agency for research on AIDS, the ARC Fondation for cancer research, the Ligue contre le cancer, and the Fondation pour la Recherche Médicale, to name a few).
With more than 100 scientific publications per year, many of them in prestigious journals, a dozen start-ups created since 2000, and multiple partnerships with industry and the clinic, IPBS is a world leader in the discovery, characterization, validation and exploitation of new biological targets in the fields of cancer, infection and inflammation.
We, the Directors of the IPBS, are extremely proud of the achievements of the Institute to date. We hope to keep our institute deeply embedded in both national and international networks, with strong connections with industry and clinics in order to ensure the best environment for the further development of knowledge, technology and innovation.
You wish to work on cancer, infectious or inflammatory diseases, with cutting-edge approaches in cellular, molecular and structural biology, in a rich and stimulating environment? Join us!
Dr. Olivier Neyrolles, Director
Prof. Catherine Muller, Deputy director
Prof. Fabrice Dumas, Deputy director
Toulouse and the Occitanie Region, a rich environment for scientists…
Situated between the Mediterranean Sea and the Atlantic Ocean, in the heart of Southern France and close to the Pyrenees mountain range, Toulouse has long been a major crossroad in Europe. Attracting 15,000 newcomers every year, Toulouse, the capital of the Occitanie region has been growing fast both demographically and economically. It boasts a particularly rich and vibrant cultural and artistic heritage.
Within the leading French region for research and innovation - with around 30,000 researchers and 3.7 % of its GDP spent on research (2014) – Toulouse has an international reputation for its cutting-edge aerospace, agronomic, health and economic research centers. Over 110,000 students, among whom 11,000 come from all over the world, pursue their studies in Toulouse, one of the most dynamic student cities in France.
